The changing role of economic evaluation in valuing medical technologies

被引:0
|
作者
Rotter, Jason S. [1 ]
Foerster, Douglas [2 ,3 ]
Bridges, John F. P. [1 ,4 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA
[2] Abbott Prod Operat AG, Allschwil, Switzerland
[3] Univ Bielefeld, Sch Publ Hlth, D-33615 Bielefeld, Germany
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
关键词
economic evaluation; health-technology assessment; medical technologies; pricing; value; ANALYTIC HIERARCHY PROCESS; COST-EFFECTIVENESS ANALYSIS; MULTICRITERIA DECISION-ANALYSIS; CONJOINT-ANALYSIS APPLICATIONS; WILLINGNESS-TO-PAY; HEALTH-CARE; PATIENT PREFERENCES; NATIONAL INSTITUTE; PROCESS UTILITY; UNITED-KINGDOM;
D O I
10.1586/ERP.12.73
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Economic evaluation is established within health-technology assessment but is challenged by those wanting to use economic evaluation to inform pricing and/or incorporate nontraditional sources of value and the views of diverse stakeholders. The changing role of economic evaluation in (formally or informally) assessing prices/values in four jurisdictions (UK, Australia, Germany and USA) is detailed and the authors propose a taxonomy of factors impacting the value of medical technology spanning clinical utility (effectiveness, safety/tolerability and quality of evidence), consumer demand (consumer preferences, process utility and unmet need), economic incentives (innovation, option value and market competition) and the societal perspective (social justice, social values and national interest). The authors suggest that multicriteria decision analysis methods grounded in hedonic-pricing theory can facilitate the valuing/pricing of medical technologies. The use of such an approach is hindered by a paucity of relevant educational opportunities, vested interests and aversion to placing prices/values on health.
引用
收藏
页码:711 / 723
页数:13
相关论文
共 50 条
  • [31] The changing role of dissection in medical education
    Gregory, SR
    Cole, TR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (09): : 1180 - 1181
  • [32] The role of the medical director: Changing with the times
    Maddux, Franklin W.
    Maddux, Dugan W.
    Hakim, Raymond M.
    SEMINARS IN DIALYSIS, 2008, 21 (01) : 54 - 57
  • [33] Valuing Medical Innovation
    Hemel, Daniel J.
    Ouellette, Lisa Larrimore
    STANFORD LAW REVIEW, 2023, 75 (03) : 517 - 599
  • [34] Potential Benefit: A New Methodological Framework for Economic Evaluation of Adherence Promotion in Existing Medical Technologies
    Dickerson, John F.
    Lynch, F. L.
    Clarke, G.
    Basu, A.
    Weersing, V. R.
    Beardslee, W. R.
    Brent, D. A.
    Gladstone, T.
    Porta, G.
    Hollon, S.
    Chan, G.
    Liu, C. F.
    Garber, J.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 : S9 - S9
  • [35] Valuing medical work
    Deeble, JS
    MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (01) : 7 - 7
  • [36] An Evaluation of Technologies for the Pseudonymization of Medical Data
    Neubauer, Thomas
    Kolb, Mathias
    COMPUTER AND INFORMATION SCIENCE 2009, 2009, 208 : 47 - 60
  • [37] EVALUATION OF MEDICAL TECHNOLOGIES WITH UNCERTAIN BENEFITS
    Phelps, C.
    Lakdawalla, D. N.
    VALUE IN HEALTH, 2019, 22 : S774 - S774
  • [38] Cognitive evaluation of innovative medical technologies
    Kushniruk, A
    Kaufman, D
    Patel, V
    PROCEEDINGS OF THE NINETEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, 1997, : 977 - 977
  • [39] MEDICAL TECHNOLOGIST AND EVALUATION OF HEALTH TECHNOLOGIES
    PEDDECORD, KM
    AMERICAN JOURNAL OF MEDICAL TECHNOLOGY, 1980, 46 (01): : 30 - 32
  • [40] Economic impacts of changing technologies on New Zealand homecare delivery
    Hennessy, Julia Lesley
    Rodrigues, Averyl
    JOURNAL OF ENABLING TECHNOLOGIES, 2019, 13 (03) : 188 - 200